U-Screen Dx Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Out of Business

U-Screen Dx General Information

Description

Developer of cancer screening tests designed to detect cancer in the early stage. The company's tests is an early-stage biotech enterprise developing screening tests focused on infection-related cancers such as hepatitis B virus (HBV)-induced liver cancer, enabling doctors to accurately and simultaneously detect both genetic and epigenetic circulating DNA markers in urine and blood.

Contact Information

Website
www.u-screendx.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (484) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

U-Screen Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 28-Nov-2020 Completed Out of Business
2. Grant 01-Jan-2015 00000 Completed Generating Revenue
1. Accelerator/Incubator 11-Jul-2014 Completed Generating Revenue
To view U-Screen Dx’s complete valuation and funding history, request access »

U-Screen Dx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial